Company news

Coiled Therapeutics PLC news in 2026

Coiled Therapeutics PLC's news releases, calls and decks from 2026, newest first.

View company

Investor Presentation via Engage Investor

October 1, 2026

Participation in The Small Cap Showcase

September 30, 2026

Interim Results to 30 June 2026

September 28, 2026

Successful Enrolment Completed Across Two Cohorts

September 21, 2026

Appointment of Joint Corporate Broker

September 1, 2026

Change of Registered Office

August 10, 2026

First Patient Dosed with new Formulation of AO-252

August 3, 2026

Coiled Advances Next-Generation AO-252 Formulation

July 7, 2026

Appointment of Independent Non-Executive Director

June 24, 2026

Life Sciences Investor Forum

June 19, 2026

Proactive One2One Investor Forum

June 18, 2026

Grant of Share Options

June 17, 2026

Appointment of Ozgur Sahin as Scientific Advisor

June 8, 2026

Attendance at Endless Frontier Labs 2026

May 7, 2026

Presentation at 18th Annual World Cancer Congress

April 15, 2026

Clinical Trial Update

April 8, 2026

Total Voting Rights

April 1, 2026

Readmission - Roquefort Therapeutics Plc

March 27, 2026

Investor Presentation

March 26, 2026

Lyramid SPA & MK Cell License Update

March 25, 2026

Schedule One - Roquefort Therapeutics PLC

March 2, 2026

Transaction Update & Notice of Intention to Delist

February 25, 2026

Research Note Published

January 15, 2026

Decks in 2026